Premashis Kar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Premashis Kar has a total of 150 co-authors. Here are the top co-authors by number of shared publications:
A Jain
13 shared publicationsK Das
12 shared publicationsR K Gupta
7 shared publicationsP Gangwal
6 shared publicationsB C Das
5 shared publicationsMohammad Asim
Department of Medicine, Maulana Azad Medical College, University Of Delhi, New Delhi, India
5 shared publications
Latest Publications
- 1 January 2016
- Published by Elsevier in Journal of Hepatology
- Vol. 64  (2) , S397-S398
HLA-DRB1*1501/1502 Allele Predicts Spontaneous Clearance of Hepatitis B Virus Infection
- 1 January 2016
- Published by Elsevier in Journal of Hepatology
- Vol. 64  (2) , S397-S398
HLA-DRB1*1501/1502 Allele Predicts Spontaneous Clearance of Hepatitis B Virus Infection
- 1 April 2015
- Published by Elsevier in Journal of Hepatology
- Vol. 62, S544-S545
P0608 : Can MBL2 genotypes and its polymorphism predict the occurrence of cirrhosis and hepatocellular carcinoma?
- 1 April 2015
- Published by Elsevier in Journal of Hepatology
- Vol. 62, S544-S545
P0608 : Can MBL2 genotypes and its polymorphism predict the occurrence of cirrhosis and hepatocellular carcinoma?
- 1 April 2014
- Published by Elsevier in Journal of Hepatology
- Vol. 60  (1) , S297-S298
P686 EXTRAHEPATIC REPLICATION OF HEPATITIS E VIRUS IN HUMAN PLACENTA: ITS CLINICAL IMPLICATIONS
- 1 April 2014
- Published by Elsevier in Journal of Hepatology
- Vol. 60  (1) , S297-S298
P686 EXTRAHEPATIC REPLICATION OF HEPATITIS E VIRUS IN HUMAN PLACENTA: ITS CLINICAL IMPLICATIONS
- 1 April 2013
- Published by Elsevier in Journal of Hepatology
- Vol. 58, S413
1001 EXPRESSION ANALYSIS OF NF-ÎşB IN PATIENTS WITH ACUTE LIVER FAILURE DURING PREGNANCY
- 1 April 2013
- Published by Elsevier in Journal of Hepatology
- Vol. 58, S413
1001 EXPRESSION ANALYSIS OF NF-ÎşB IN PATIENTS WITH ACUTE LIVER FAILURE DURING PREGNANCY
- 1 July 2012
- Vol. 60, 53-5
Eosinophilic ascites. A rare presentation of eosinophilic gastroenteritis.
EGED is a rare entity; it should be kept in mind in patient of unexplained abdominal symptoms. Any age group and any part of GI tract can be involved. Eosinophillia may be absent in the peripheral smear and biopsy may be negative in up to 10% of the cases. Here we are reporting a 40 years old male who presented to us with eosinophilic ascites, a rare presentation of serosal variant of eosinophilic gastroenteritis (EGED).
- 1 July 2012
- Vol. 60, 53-5
Eosinophilic ascites. A rare presentation of eosinophilic gastroenteritis.
EGED is a rare entity; it should be kept in mind in patient of unexplained abdominal symptoms. Any age group and any part of GI tract can be involved. Eosinophillia may be absent in the peripheral smear and biopsy may be negative in up to 10% of the cases. Here we are reporting a 40 years old male who presented to us with eosinophilic ascites, a rare presentation of serosal variant of eosinophilic gastroenteritis (EGED).
- Open Access
- 23 May 2011
- Published by Springer Nature in Virology Journal
- Vol. 8  (1) , 254
Immunological and molecular epidemiological characteristics of acute and fulminant viral hepatitis A
Hepatitis A virus is an infection of liver; it is hyperendemic in vast areas of the world including India. In most cases it causes an acute self limited illness but rarely fulminant. There is growing concern about change in pattern from asymptomatic childhood infection to an increased incidence of symptomatic disease in the adult population.
- 23 May 2011
- Published by Springer Nature in Virology Journal
- Vol. 8  (1) , 254
Open AccessImmunological and molecular epidemiological characteristics of acute and fulminant viral hepatitis A
Hepatitis A virus is an infection of liver; it is hyperendemic in vast areas of the world including India. In most cases it causes an acute self limited illness but rarely fulminant. There is growing concern about change in pattern from asymptomatic childhood infection to an increased incidence of symptomatic disease in the adult population.
- 31 March 2011
- Published by Elsevier in Journal of Clinical and Experimental Hepatology
- Vol. 1  (1) , 6-7
Expression Analysis of Proteins Inducing Interferon in Chronic Hepatitis C Patients
- 31 March 2011
- Published by Elsevier in Journal of Clinical and Experimental Hepatology
- Vol. 1  (1) , 6-7
Expression Analysis of Proteins Inducing Interferon in Chronic Hepatitis C Patients
- 1 September 2010
- Vol. 132, 312-7
Significance of anti-HBc screening of blood donors and its association with occult hepatitis B virus infection: Implications for blood transfusion.
Expansions of blood donor screening and improved laboratory detection of viral markers have remarkably reduced the risk for infection with transfusion-transmitted viruses. This study was aimed to evaluate the presence of anti-HBc and to determine the presence or absence of HBV DNA in the serum samples from HBsAg negative, anti-HBc positive blood donors in a tertiary care hospital blood bank from Delhi. A total of 2175 HBsAg negative, first time volunteer blood donors were included in the study from blood bank, Lok Nayak Hospital, New Delhi. The blood specimens from all these subjects were evaluated for anti-HBV-core antigen (anti-HBc) serology, anti-HBV-surface antigen (anti-HBs) titres and HBeAg. The presence of HBV DNA was evaluated by testing, through polymerase chain reaction (PCR) techniques. Of the 2175 HBsAg negative voluntary blood donors, 413 (19.8%) were tested to be positive for anti-HBc alone. Of these, 153 (group-I) were anti-HBs negative whereas group-II comprises a total of 260 anti-HBs positive cases i.e. 89 out of 413 had anti-HBs titres of 10-99 IU/l and the remaining 171 had anti-HBs titres of 100-500 IU/l. HBV DNA was detected in 7.5 per cent anti-HBc positive samples irrespective of anti-HBs status. Our results showed that 18.9 per cent of our donor population was anti-HBc reactive, and hence inclusion of anti-HBc testing will lead to a high discard rate. The presence of HBV DNA in fairly high percentage of anti-HBc positive samples highlighted the need for a stringent and better screening system to prevent occult HBV infection.
- 1 September 2010
- Vol. 132, 312-7
Significance of anti-HBc screening of blood donors and its association with occult hepatitis B virus infection: Implications for blood transfusion.
Expansions of blood donor screening and improved laboratory detection of viral markers have remarkably reduced the risk for infection with transfusion-transmitted viruses. This study was aimed to evaluate the presence of anti-HBc and to determine the presence or absence of HBV DNA in the serum samples from HBsAg negative, anti-HBc positive blood donors in a tertiary care hospital blood bank from Delhi. A total of 2175 HBsAg negative, first time volunteer blood donors were included in the study from blood bank, Lok Nayak Hospital, New Delhi. The blood specimens from all these subjects were evaluated for anti-HBV-core antigen (anti-HBc) serology, anti-HBV-surface antigen (anti-HBs) titres and HBeAg. The presence of HBV DNA was evaluated by testing, through polymerase chain reaction (PCR) techniques. Of the 2175 HBsAg negative voluntary blood donors, 413 (19.8%) were tested to be positive for anti-HBc alone. Of these, 153 (group-I) were anti-HBs negative whereas group-II comprises a total of 260 anti-HBs positive cases i.e. 89 out of 413 had anti-HBs titres of 10-99 IU/l and the remaining 171 had anti-HBs titres of 100-500 IU/l. HBV DNA was detected in 7.5 per cent anti-HBc positive samples irrespective of anti-HBs status. Our results showed that 18.9 per cent of our donor population was anti-HBc reactive, and hence inclusion of anti-HBc testing will lead to a high discard rate. The presence of HBV DNA in fairly high percentage of anti-HBc positive samples highlighted the need for a stringent and better screening system to prevent occult HBV infection.
- 30 April 2010
- Published by Elsevier in Journal of Hepatology
- Vol. 52, S233
589 MOLECULAR EPIDEMIOLOGY OF HEPATOCELLULAR CARCINOMA IN INDIA WITH SPECIAL REFERENCE TO GLUTATHIONE S TRANSFERASES GENE POLYMORPHISM
- 30 April 2010
- Published by Elsevier in Journal of Hepatology
- Vol. 52, S233
589 MOLECULAR EPIDEMIOLOGY OF HEPATOCELLULAR CARCINOMA IN INDIA WITH SPECIAL REFERENCE TO GLUTATHIONE S TRANSFERASES GENE POLYMORPHISM
- 1 April 2010
- Vol. 131, 545-54
Clinical & molecular characterization of human TT virus in different liver diseases.
TT virus (TTV) is a newly discovered non-enveloped, single stranded DNA virus of high genotypic variability, found frequently in patients with acute or chronic hepatitis of non A-G aetiology. This study was carried out to look for the presence of TTV and its genotypes in patients with different types of liver diseases from northern India. A total of 262 serum samples from patients of acute viral hepatitis (AVH; n=72), fulminant hepatic failure (FHF; n=49), chronic active hepatitis (CAH; n=93) and liver cirrhosis (LC; n=48), were analyzed for hepatitis A-G viral markers. TTV DNA was detected in all cases by nested polymerase chain reaction (PCR) using the primers from N22 and untranslated (UTR) region. TTV-DNA was also tested in 150 volunteer blood donors. Direct nucleotide sequencing of N22 amplicons were carried out to look into the prevalent TTV genotypes. TTV-DNA was detected in 73.6, 59.2, 21.5 and 29.1 per cent cases with AVH, FHF, CAH and cirrhosis, respectively. In AVH and FHF groups, TTV showed co-infection with all A-G hepatitis cases whereas in CAH and cirrhosis groups, TTV co-infection observed with HBV, HCV and HGV. TTV-DNA was detected in 45.3 per cent volunteer blood donors. No statistically significant difference was observed amongst the mean liver function profile of UTR PCR positive and negative cases in different liver disease groups except AVH cases, in whom the various biochemical parameters between TTV positive and TTV negative patients were marginally significant. However, no significant evidence of biochemical or histological deterioration of the liver was observed in TTV positive cases amongst FHF, CAH and cirrhosis. Predominance of genotype 1a was observed in all the cases from north India. TTV is a frequent virus isolated from patients with various types of liver diseases as well as in healthy individuals from northern India. TTV has no effect on biochemical markers of associated liver diseases. Genotype 1a was the most predominant type in different liver disease groups. The occurrence of TTV did not further influence the course of the disease.
- 1 April 2010
- Vol. 131, 545-54
Clinical & molecular characterization of human TT virus in different liver diseases.
TT virus (TTV) is a newly discovered non-enveloped, single stranded DNA virus of high genotypic variability, found frequently in patients with acute or chronic hepatitis of non A-G aetiology. This study was carried out to look for the presence of TTV and its genotypes in patients with different types of liver diseases from northern India. A total of 262 serum samples from patients of acute viral hepatitis (AVH; n=72), fulminant hepatic failure (FHF; n=49), chronic active hepatitis (CAH; n=93) and liver cirrhosis (LC; n=48), were analyzed for hepatitis A-G viral markers. TTV DNA was detected in all cases by nested polymerase chain reaction (PCR) using the primers from N22 and untranslated (UTR) region. TTV-DNA was also tested in 150 volunteer blood donors. Direct nucleotide sequencing of N22 amplicons were carried out to look into the prevalent TTV genotypes. TTV-DNA was detected in 73.6, 59.2, 21.5 and 29.1 per cent cases with AVH, FHF, CAH and cirrhosis, respectively. In AVH and FHF groups, TTV showed co-infection with all A-G hepatitis cases whereas in CAH and cirrhosis groups, TTV co-infection observed with HBV, HCV and HGV. TTV-DNA was detected in 45.3 per cent volunteer blood donors. No statistically significant difference was observed amongst the mean liver function profile of UTR PCR positive and negative cases in different liver disease groups except AVH cases, in whom the various biochemical parameters between TTV positive and TTV negative patients were marginally significant. However, no significant evidence of biochemical or histological deterioration of the liver was observed in TTV positive cases amongst FHF, CAH and cirrhosis. Predominance of genotype 1a was observed in all the cases from north India. TTV is a frequent virus isolated from patients with various types of liver diseases as well as in healthy individuals from northern India. TTV has no effect on biochemical markers of associated liver diseases. Genotype 1a was the most predominant type in different liver disease groups. The occurrence of TTV did not further influence the course of the disease.